Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 11

1.

Identification of chromosomal genes in Yersinia pestis that influence type III secretion and delivery of Yops into target cells.

Houppert AS, Kwiatkowski E, Glass EM, DeBord KL, Merritt PM, Schneewind O, Marketon MM.

PLoS One. 2012;7(3):e34039. doi: 10.1371/journal.pone.0034039. Epub 2012 Mar 30.

2.

Characterization of an F1 deletion mutant of Yersinia pestis CO92, pathogenic role of F1 antigen in bubonic and pneumonic plague, and evaluation of sensitivity and specificity of F1 antigen capture-based dipsticks.

Sha J, Endsley JJ, Kirtley ML, Foltz SM, Huante MB, Erova TE, Kozlova EV, Popov VL, Yeager LA, Zudina IV, Motin VL, Peterson JW, DeBord KL, Chopra AK.

J Clin Microbiol. 2011 May;49(5):1708-15. doi: 10.1128/JCM.00064-11. Epub 2011 Mar 2.

3.

Pneumonic plague pathogenesis and immunity in Brown Norway rats.

Anderson DM, Ciletti NA, Lee-Lewis H, Elli D, Segal J, DeBord KL, Overheim KA, Tretiakova M, Brubaker RR, Schneewind O.

Am J Pathol. 2009 Mar;174(3):910-21. doi: 10.2353/ajpath.2009.071168. Epub 2009 Jan 22.

4.

Immunogenicity and protective immunity against bubonic plague and pneumonic plague by immunization of mice with the recombinant V10 antigen, a variant of LcrV.

DeBord KL, Anderson DM, Marketon MM, Overheim KA, DePaolo RW, Ciletti NA, Jabri B, Schneewind O.

Infect Immun. 2006 Aug;74(8):4910-4.

5.

Plague bacteria target immune cells during infection.

Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O.

Science. 2005 Sep 9;309(5741):1739-41. Epub 2005 Jul 28.

6.

LcrV plague vaccine with altered immunomodulatory properties.

Overheim KA, Depaolo RW, Debord KL, Morrin EM, Anderson DM, Green NM, Brubaker RR, Jabri B, Schneewind O.

Infect Immun. 2005 Aug;73(8):5152-9.

7.

Bacillus anthracis sortase A (SrtA) anchors LPXTG motif-containing surface proteins to the cell wall envelope.

Gaspar AH, Marraffini LA, Glass EM, Debord KL, Ton-That H, Schneewind O.

J Bacteriol. 2005 Jul;187(13):4646-55.

8.

Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections.

Mattner J, Debord KL, Ismail N, Goff RD, Cantu C 3rd, Zhou D, Saint-Mezard P, Wang V, Gao Y, Yin N, Hoebe K, Schneewind O, Walker D, Beutler B, Teyton L, Savage PB, Bendelac A.

Nature. 2005 Mar 24;434(7032):525-9.

9.

Iron-source preference of Staphylococcus aureus infections.

Skaar EP, Humayun M, Bae T, DeBord KL, Schneewind O.

Science. 2004 Sep 10;305(5690):1626-8.

10.
11.

Roles of LcrG and LcrV during type III targeting of effector Yops by Yersinia enterocolitica.

DeBord KL, Lee VT, Schneewind O.

J Bacteriol. 2001 Aug;183(15):4588-98.

Supplemental Content

Loading ...
Support Center